Prognose

Für dieses Unternehmen liegen uns keine Analysten-Daten vor.

Scoring-Modelle

Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.

SS Innovations: A Speculative Bet On Robotic Surgeries
SSII is rapidly growing its surgical robotics business, with strong revenue and KPI growth while expanding into new international markets. Despite operating losses and dilution risk, I see a path to profitability as installations and instrument sales accelerate. The stock is aggressively valued, but industry-leading growth and sector hype justify a speculative buy for risk-tolerant investors.» Mehr auf seekingalpha.com
SS Innovations Announces Successful Completion of First Robotic Cardiac Surgery in the Western Hemisphere Utilizing the Company's SSi Mantra 3 Surgical Robotic System
Surgery performed by Dr. Juan Zuniga at Interhospital in Guayaquil, Ecuador PR Audio: Fort Lauderdale, FL, June 16, 2025 – PRISM MediaWire – SS Innovations International, Inc.» Mehr auf prismmediawire.com
SS Innovations Announces Successful Completion of First Robotic Cardiac Surgery in the Western Hemisphere Utilizing the Company's SSi Mantra 3 Surgical Robotic System
SS Innovations Announces Completion of First Robotic Cardiac Surgery in the Western Hemisphere Utilizing the Company's SSi Mantra 3 Surgical Robotic System» Mehr auf globenewswire.com

Im letzten Quartal hatte SS INNOVATIONS INTERNAT. einen Umsatz von 5,40 Mio€ und ein Nettoeinkommen von −7,16 Mio€